XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:    
Research and development, net $ 3,456 $ 977
General and administrative 1,472 1,330
Operating loss (4,928) (2,307)
Financial expenses (income), net 99 (9)
Net loss $ (5,027) $ (2,298)
Basic and diluted net loss per share from continuing operations $ (0.24) $ (0.12)
Weighted average number of shares outstanding used in computing basic and diluted net loss per share 20,917,329 19,047,350